Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Verification of Biomarkers to Examine Neonatal Asphyxia-induced Hypoxic-ischemic Encephalopathy Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test

NCT04714502 is registered in ClinicalTrials.gov with InfanDx AG as lead sponsor.

NCT NCT04714502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Verification of Biomarkers to Examine Neonatal Asphyxia-induced Hypoxic-ischemic Encephalopathy Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test
Lead sponsor
InfanDx AG
Phase
Observational
Overall status
Unknown status
Start date
July 2, 2019
Completion date
December 31, 2021
Enrollment
144 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

birth asphyxia